Results 91 to 100 of about 14,996 (221)

Primary mediastinal seminoma

open access: yes, 1983
Çok ender görülen tümörlerden olan bir Primer Mediasten Seminoma olgusu sunulmuş ve bu konudaki kaynaklar gözden geçirilmiştir.A case of Primary Mediastinal Seminoma, which is very rarely seen, is presented and literature on this subject is ...

core  

Pattern‐based interpretation of SOX2 expression in ovarian teratomas: avoiding diagnostic pitfalls in the distinction between immature and mature neuroectodermal elements

open access: yesHistopathology, EarlyView.
Ovarian immature teratoma grading may be confounded by mature neuroectodermal mimics. SOX2 labelled immature neuroepithelium but also mature ependymal and glial tissue, while SALL4 was negative in mature mimics and variably expressed in immature neuroepithelium.
Agnese Orsatti   +14 more
wiley   +1 more source

Testicular cancer: seminoma

open access: yes, 2007
More than half of painless solid swellings of the body of the testis are malignant, with a peak incidence in men aged 25-35 years. About half of testicular cancers are seminomas, which tend to affect older men and have a good prognosis.
Stuart, N.   +2 more
core   +4 more sources

Thymic Seminoma with Regressive Changes Obscured by Granulomatous Reaction

open access: yes, 2022
Primary thymic seminoma is an exceedingly rare tumour. There are few case reports about mediastinal thymic seminoma accompanied by secondary changes.
Celik, Muhammet Reha   +5 more
core   +1 more source

“Seminoma with trophocarcinoma”.A clinical variant of seminoma [PDF]

open access: yesCancer, 1970
M, Friedman, A W, Pearlman
openaire   +2 more sources

[Rare seminoma metastasis to the corpus spongiosum and urethra].

open access: yes, 2003
Anaplastic seminomas account for 5-10% of all seminomas. Their metastatic pattern is similar to the classic form of seminoma. We report on an oligophrenic patient with seminoma pT1 who developed a metastasis to the corpus spongiosum and penile urethra ...
Fleischmann A   +4 more
core   +1 more source

The effect of time to nephrectomy on cancer‐specific mortality in pathological T stage (pT)1b–2 renal cancer

open access: yesBJU International, Volume 138, Issue 6, Page 1160-1170, December 2026.
Objective To assess the impact of prolonged time to surgery on cancer‐specific mortality (CSM) in patients with pathological T stage (pT)1b–2 N0M0 renal cell carcinoma (RCC) treated with nephrectomy (either partial [PN] or radical [RN]). Within the Surveillance, Epidemiology and End Results (SEER) database (2004–2021), we tested the effect of time to ...
Michele Nicolazzini   +17 more
wiley   +1 more source

CHRONIC MYELOGENOUS LEUKEMIA FOLLOWING RADIATION-THERAPY FOR TESTICULAR SEMINOMA

open access: yes, 1989
A 43-year-old man was treated with orchiectomy and radiotherapy for testicular seminoma. Four years later, he developed a typical Philadelphia chromosome positive chronic granulocytic leukemia.
A. IURLO, E. POLLI, A. MAIOLO, P. FOA
core   +1 more source

Safety of Lowering the Platelet Transfusion Threshold Before Central Venous Catheterisation in Patients With Haematological Diseases

open access: yesEuropean Journal of Haematology, Volume 117, Issue 6, Page 1531-1540, December 2026.
ABSTRACT Introduction Central venous catheter (CVC) insertion is frequently required in patients with haematological diseases. Despite limited evidence, thrombocytopenia often prompts prophylactic platelet transfusion before catheterisation. Methods We conducted an observational before‐and‐after study including the first non‐tunnelled CVC insertion ...
Mathias Lazarevic Lindblad   +8 more
wiley   +1 more source

Cytochrome P450 aromatase expression in human seminoma

open access: yesReproductive Biology and Endocrinology, 2005
Background The enzyme cytochrome P450 aromatase, catalysing the conversion of androgens into estrogens, has been detected in normal human testicular cells suggesting a physiological role of local estrogen biosynthesis on spermatogenesis control ...
Montanaro Daniela   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy